SCHEMBL3798245

SCHEMBL3798245

CCN1CCN(c2ccc(Nc3ncc(Br)c(Nc4ccc5ncn(Cc6ccccc6)c5c4)n3)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 9/20 0.53
▸ IGF1R P08069 3/20 0.52
▸ NTRK1 P04629 2/20 0.51
▸ CDK9 P50750 2/20 0.51
▸ CCNK O75909 1/20 0.51
▸ CCNA2 P20248 1/20 0.51
▸ CDK2 P24941 1/20 0.51
▸ CCND3 P30281 1/20 0.51
▸ CDK6 Q00534 1/20 0.51
▸ WEE1 P30291 5/20 0.51
▸ ALK Q9UM73 5/20 0.51
▸ FGFR1 P11362 3/20 0.51
▸ PDGFRA P16234 3/20 0.51
▸ AURKA O14965 2/20 0.51
▸ DAPK3 O43293 2/20 0.51
▸ JAK2 O60674 2/20 0.51
▸ PRKD3 O94806 2/20 0.51
▸ MAP4K4 O95819 2/20 0.51
▸ PAK4 O96013 2/20 0.51
▸ LCK P06239 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3800808 0.94 EGFR (0.53) EGFRIGF1RNTRK1CDK9CCNK
SCHEMBL3761412 0.80 KDM1A (0.42) EGFRIGF1RNTRK1CDK9CCNK
SCHEMBL3771267 0.78 EGFR (0.54) EGFRIGF1RNTRK1CDK9CCNK
SCHEMBL3759654 0.75 EGFR (0.83) EGFRIGF1RNTRK1CDK9WEE1
SCHEMBL3761466 0.75 KDM1A (0.42) NTRK1CDK9CCNKCCNA2CDK2
SCHEMBL3274766 0.73 IGF1R (0.77) EGFRIGF1RCDK9CCNKCCNA2
SCHEMBL3769145 0.73 WEE1 (0.62) EGFRIGF1RNTRK1CDK9WEE1
SCHEMBL15797629 0.72 EGFR (0.58) EGFRIGF1RCDK9CCNKCCNA2
SCHEMBL30270089 0.71 CYP11B1 (0.52) ERBB2BRD4
SCHEMBL655906 0.71 SYK (0.65) EGFRIGF1RNTRK1CDK9CCNK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010138578-A1 PYRIMIDINE INHIBITORS OF KINASE ACTIVITY ABBOTT LABORATORIES (US) 2010-12-02 — — WO disclosed
Send feedback